R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Authors :: Al-Sarayfi, Diana
Meeuwes, Frederik O.
Durmaz, Müjde
Issa, Djamila E.
Brouwer, Rolf E.
Beeker, Aart
van Rhenen, Anna
Mutsaers, Pim G.N.J.
Böhmer, Lara H.
van der Poel, Marjolein W.M.
Te Boome, Liane
van Meerten, Tom
Chamuleau, Martine E.D.
Zijlstra, Josée M.
Brink, Mirian
Nijland, Marcel
Al-Sarayfi, Diana
Meeuwes, Frederik O.
Durmaz, Müjde
Issa, Djamila E.
Brouwer, Rolf E.
Beeker, Aart
van Rhenen, Anna
Mutsaers, Pim G.N.J.
Böhmer, Lara H.
van der Poel, Marjolein W.M.
Te Boome, Liane
van Meerten, Tom
Chamuleau, Martine E.D.
Zijlstra, Josée M.
Brink, Mirian
Nijland, Marcel
Source :: Al-Sarayfi , D , Meeuwes , F O , Durmaz , M , Issa , D E , Brouwer , R E , Beeker , A , van Rhenen , A , Mutsaers , P G N J , Böhmer , L H , van der Poel , M W M , Te Boome , L , van Meerten , T , Chamuleau , M E D , Zijlstra , J M , Brink , M & Nijland , M 2022 , ' R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma ' , Blood Cancer Journal , vol. 12 , no. 9 , 125 , pp. 125 .
Publication Year :: 2022

Database :: OAIster
Journal :: Al-Sarayfi , D , Meeuwes , F O , Durmaz , M , Issa , D E , Brouwer , R E , Beeker , A , van Rhenen , A , Mutsaers , P G N J , Böhmer , L H , van der Poel , M W M , Te Boome , L , van Meerten , T , Chamuleau , M E D , Zijlstra , J M , Brink , M & Nijland , M 2022 , ' R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma ' , Blood Cancer Journal , vol. 12 , no. 9 , 125 , pp. 125 .
Notes :: application/pdf, English
Publication Type :: Electronic Resource
Accession number :: edsoai.on1346347643
Document Type :: Electronic Resource

Tools